Drug firms, FDA under fire over side effects of pills
6720
Americans are exposed to dangerous medicines because drug makers do not adequately disclose side effects and regulators are failing to react fast enough to safety risks, according to a prominent medical journal.
106870
At a hearing Thursday on Capitol Hill, senators excoriated top federal drug regulators for failing to realize three years ago that Vioxx, a pain pill that Merck withdrew in September, was dangerous.
603764
The pharmaceutical industry and Madison Avenue are increasingly concerned about their ability to continue to pitch prescription drugs at patients and doctors.
95505
The recent Vioxx withdrawal and  testimony from an FDA insider accusing the agency of failing to  protect public health are fueling such heightened concern over  drug safety that valuable medicines could be kept from  patients, doctors said on Friday.
544386
Scientists and European regulators are now questioning the safety of other pain relievers like Vioxx, saying these medications also might raise the risk of heart attack and stroke.
632172
A new report reveals an alarming rise in fatal or debilitating prescription drug-related side effects and raises serious questions about basic medical safety practices.
602553
U.S. lawmakers criticized the Food  and Drug Administration's monitoring of the risks of a  Sanofi-Aventis antibiotic and some other prescription drugs on  Tuesday.
362814
Saying they&#39;re concerned about drug safety and the loss of sales, the Connecticut Pharmacists Association has joined with other organizations that oppose importation of prescription drugs.
3564
A day after troubling reports about the popular pain relief drug Celebrex, more questions are being asked about the approval process for such drugs.
502595
The Food and Drug Administration is responding to the widespread criticism of the government's handling of drug safety problems.
231780
GAITHERSBURG, Md.  - Rival drug giants Pfizer Inc.  PFE.N and Merck & Co. Inc. MRK.N argued conflicting views  of the dangers of their pain relievers on Wednesday to U.S.  science advisers weighing the risks of medicines similar to  recalled arthritis drug Vioxx.
672654
The prescription drug industry has grown enormously in the past few years, to the tune of an estimated $200 billion every year. Consumers and medical professionals have sharpened their criticism of the industry
226541
A leading doctor expressed concerns about the heart risks of GlaxoSmithKline Plc's diabetes drug Avandia in a letter to the U.S. Food and Drug Administration seven years ago.
362559
Drug investors may be wishing they could pop two pills and feel better in the morning. The latest headache hit last week when Pfizer joined the rash of drug companies announcing problems with their products.
509369
The storm lashing big pharmaceutical companies over safety concerns about pain treatments such as Celebrex and Vioxx may actually blow some good in the direction of biotech stocks.
518488
The US regulator to beef up monitoring of drug safety after criticism over a painkiller linked to heart disease.
687703
The US Food and Drug Administration (FDA) defended its approval of five prescription medications which a staffer dubbed unsafe when he warned the drugs present possible risks so severe they should face tougher restrictions or be pulled off the market.